Enhanced liver functions in mouse hepatoma cells by induced overexpression of liver-enriched transcription factors

Biochemical Engineering Journal

Volumn 60, Issue , 2012, Pages 67-73

  Yamamoto, Hideaki ^a   Kawabe, Yoshinori ^a   Ito, Akira ^a   Kamihira, Masamichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Animal cell culture; Biomedical; Hepatoma cell; Liver function; Liver enriched transcription factor; Recombinant DNA

Indexed keywords

BIOARTIFICIAL LIVER SUPPORT SYSTEM; BIOMEDICAL; CCAAT/ENHANCER-BINDING PROTEINS; CELL CLONES; CULTURE CONDITIONS; GENETIC MODIFICATIONS; HEPATIC DIFFERENTIATION; HEPATOCYTE NUCLEAR FACTORS; HEPATOCYTES; HEPATOMA CELLS; INDUCIBLE EXPRESSION; LIVER-SPECIFIC GENES; MOUSE LIVER; OVER-EXPRESSION; RECOMBINANT DNA; RETROVIRAL VECTORS;

ANIMAL CELL CULTURE; ARTIFICIAL ORGANS; CELL PROLIFERATION; CYTOLOGY; GENES; GENETIC ENGINEERING; MAMMALS; TRANSCRIPTION; TRANSCRIPTION FACTORS; TUMORS;

CLONE CELLS;

CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HEPATOCYTE NUCLEAR FACTOR 1BETA; HEPATOCYTE NUCLEAR FACTOR 3BETA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HEPATOCYTE NUCLEAR FACTOR 6; RETROVIRUS VECTOR; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CLONE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENE OVEREXPRESSION; GENE VECTOR; GENETIC ENGINEERING; GENETIC TRANSCRIPTION; GENETIC TRANSDUCTION; HEPATOMA CELL; LIVER FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 83555176233     PISSN: 1369703X     EISSN: 1873295X     Source Type: Journal    
DOI: 10.1016/j.bej.2011.10.004     Document Type: Article

References (20)

1. Bellentani S., Tiribelli C. The spectrum of liver disease in the general population: lesson from the Dionysos study. J. Hepatol. 2001, 35:531-537.
2. Neuberger J. Liver transplantation. J. Hepatol. 2000, 32:198-207.
3. Park J.K., Lee D.H. Bioartificial liver systems: current status and future perspective. J. Biosci. Bioeng. 2005, 99:311-319.
4. Kobayashi N., Okitsu T., Nakaji S., Tanaka N. Hybrid bioartificial liver: establishing a reversibly immortalized human hepatocyte line and developing a bioartificial liver for practical use. J. Artif. Organs 2003, 6:236-244.
5. Schrem H., Klempnauer J., Borlak J. Liver-enriched transcription factors in liver function and development. Part I: the hepatocyte nuclear factor network and liver-specific gene expression. Pharmacol. Rev. 2002, 54:129-158.
6. Cereghini S. Liver-enriched transcription factors and hepatocyte differentiation. FASEB J. 1996, 10:267-282.
7. Nagaki M., Moriwaki H. Transcription factor HNF and hepatocyte differentiation. Hepatol. Res. 2008, 38:961-969.
8. Hawley R.G., Lieu F.H., Fong A.Z., Hawley T.S. Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1994, 1:136-138.
9. Akiyama H., Ito A., Kawabe Y., Kamihira M. Genetically engineered angiogenic cell sheets using magnetic force-based gene delivery and tissue fabrication techniques. Biomaterials 2010, 31:1251-1259.
10. Penno C.A., Kawabe Y., Ito A., Kamihira M. Production of recombinant human erythropoietin/Fc fusion protein by genetically manipulated chickens. Transgenic Res. 2010, 19:187-195.
11. Hotta A., Saito Y., Kyogoku K., Kawabe Y., Nishijima K., Kamihira M., Iijima S. Characterization of transient expression system for retroviral vector production. J. Biosci. Bioeng. 2006, 101:361-368.
12. Iacob R., Rüdrich U., Rothe M., Kirsch S., Maasoumy B., Narain N., Verfaillie C.M., Sancho-Bru P., Iken M., Popescu I., Schambach A., Manns M.P., Bock M. Induction of a mature hepatocyte phenotype in adult liver derived progenitor cells by ectopic expression of transcription factors. Stem Cell Res. 2011, 6:251-261.
13. Yamada K., Kamihira M., Iijima S. Enhanced cell aggregation and liver functions using polymers modified with a cell-specific ligand in primary hepatocyte cultures. J. Biosci. Bioeng. 1999, 88:557-562.
14. Haber B.A., Chin S., Chuang E., Buikhuisen W., Naji A., Taub R. High levels of glucose-6-phosphatase gene and protein expression reflect an adaptive response in proliferating liver and diabetes. J. Clin. Invest. 1995, 95:832-841.
15. Noda C., Fukushima C., Fujiwara T., Matsuda K., Kobune Y., Ichihara A. Developmental regulation of rat serine dehydratase gene expression: evidence for the presence of a repressor in fetal hepatocytes. Biochim. Biophys. Acta. 1994, 1217:163-173.
16. Li J., Ning G., Duncan S.A. Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha. Genes Dev. 2000, 14:464-474.
17. Parviz F., Matullo C., Garrison W.D., Savatski L., Adamson J.W., Ning G., Kaestner K.H., Rossi J.M., Zaret K.S., Duncan S.A. Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis. Nat. Genet. 2003, 34:292-296.
18. Yin C., Lin Y., Zhang X., Chen Y.X., Zeng X., Yue H.Y., Hou J.L., Deng X., Zhang J.P., Han Z.G., Xie W.F. Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene. Hepatology 2008, 48:1528-1539.
19. Hamamoto R., Yamada K., Kamihira M., Iijima S. Differentiation and proliferation of primary rat hepatocytes cultured as spheroids. J. Biochem. 1998, 124:972-979.
20. Fukuda J., Okamura K., Ishihara K., Mizumoto H., Nakazawa K., Ijima H., Kajiwara T., Funatsu K. Differentiation effects by the combination of spheroid formation and sodium butyrate treatment in human hepatoblastoma cell line (Hep G2): a possible cell source for hybrid artificial liver. Cell Transplant. 2005, 14:819-827.